Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · IEX Real-Time Price · USD
0.937
-0.023 (-2.42%)
At close: Jul 19, 2024, 4:00 PM
0.965
+0.028 (3.02%)
Pre-market: Jul 22, 2024, 8:00 AM EDT
Compass Therapeutics Employees
Compass Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
n/a
Profits / Employee
-$1,420,125
Market Cap
128.89M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 416 |
| Agenus | 389 |
| Veru Inc. | 189 |
| X4 Pharmaceuticals | 93 |
| Immunic | 77 |
| Relmada Therapeutics | 20 |
| Annovis Bio | 16 |
| CervoMed | 8 |
CMPX News
- 7 weeks ago - Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Compass Therapeutics Announces CEO Transition - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Mee - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference - GlobeNewsWire
- 2 months ago - Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics to Participate in the Stifel Targeted Oncology Days - GlobeNewsWire
- 3 months ago - Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire